In 2022 the company made a revenue of N/A a decrease over the years 2021 revenue that were of N/A.The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.
Year | Revenue | Change |
---|---|---|
2023 (TTM) | N/A | |
2022 | N/A | |
2021 | N/A | -100% |
2020 | $41.17 M | |
2019 | N/A | |
2018 | N/A | |
2017 | N/A | |
2016 | N/A | |
2015 | N/A | |
2014 | N/A | |
2013 | N/A |
Company | Revenue | Revenue differencediff. | Country |
---|---|---|---|
Incyte INCY | $3.69 B | N/A | ๐บ๐ธ USA |
Dynavax Technologies
DVAX | $0.23 B | N/A | ๐บ๐ธ USA |
Clovis Oncology CLVS | $0.13 B | N/A | ๐บ๐ธ USA |